Stay updated on Belantamab vs Bortezomib in MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page; no user-facing content or functional changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded related topics: Multiple Myeloma and MedlinePlus Genetics to the Study Details page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a unified Locations section with listed sites across Arizona, Florida, Massachusetts, Missouri, Tennessee, Australian Capital Territory, New South Wales, Queensland, South Australia, Victoria, and Western Australia, and updated the revision to v3.3.3; the previous separate location subpages (Arizona Locations, Florida Locations, etc.) were removed.SummaryDifference0.6%

- Check38 days agoChange DetectedAdded related topics (Multiple myeloma and MedlinePlus Genetics) and updated the Publications section with a 2025 Blood Advances article, while removing the earlier Blood Advances citation.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page footer revision label updated from v3.3.1 to v3.3.2, with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page adds a note that publications are automatically filled from PubMed and updates the revision tag to v3.3.1. No substantive study information is changed.SummaryDifference0.1%

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.